What is Ceapro Inc. (CRPOF)?

Ceapro Inc. (CRPOF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of CRPOF?

The current price of CRPOF is $0.17. Prices are updated in real time on Stocks360.

What is CRPOF's price-to-earnings (PE) ratio?

CRPOF's trailing twelve-month PE ratio is -3.94, based on current price and earnings per share data available on Stocks360.

What is CRPOF's market capitalization?

CRPOF's market capitalization is $13,309,844.00, placing it in the small-cap tier.

Ceapro Inc. (CRPOF)

Stock analysis · OTC · Healthcare · Biotechnology

$0.17

Market Cap

$13.31M

PE (TTM)

-3.94

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.38

Day Range

$0.17 – $0.17

52-wk Range

$0.12 – $0.40

Avg Volume

N/A

Volume

6.00K

Ceapro Inc. (CRPOF) is a publicly traded company in the Healthcare sector. Latest price: $0.17. Market cap $13.31M. Trailing PE -3.94. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Ceapro Inc.

Operating as a biotechnology enterprise, Ceapro Inc. is dedicated to pioneering and bringing to market health and wellness offerings, alongside their underlying technologies, which are all predicated on plant-derived compounds. Its commercial reach extends across the United States, Germany, China, Canada, and various other global markets. The company's operations are divided into two principal sectors. The first, its Active Ingredient Product Technology division, is centered on inventing and employing exclusive extraction methodologies. These are utilized for the manufacturing, refinement, and sale of potent substances like oat beta glucan and avenanthramides, extracted from oats and other sustainable botanical sources, serving both the healthcare and beauty industries. Conversely, the Cosmeceutical Industry segment concentrates on the creation and commercial release of anti-aging goods. These products, formulated from natural active components, are primarily distributed straight to consumers through the company's online portal and via a network of specialized natural product retailers. Established in 1997, Ceapro Inc.'s main corporate office is located in Edmonton, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-3.94×
P/S (TTM)	1.93×
P/B	0.67×
PEG	0.04×
P/FCF (TTM)	-4.03×
EV / EBITDA	-3.13×
EV / Sales	1.24×
Earnings Yield	-25.37%
Free Cash Flow Yield	-24.79%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$11.98M
Revenue (TTM)	$9.63M
Net Income (TTM)	-$4.71M
Free Cash Flow (TTM)	-$4.50M
Net Debt	-$6.60M
Working Capital	$13.11M
Gross Margin	36.99%
Operating Margin	-64.93%
Net Margin	-48.89%
Return on Equity	-15.66%
Return on Invested Capital	-16.57%